This hypothesis was further confirmed with a recent study, wherein a better response was detected in patients undergoing chemotherapy after PUMA induction, further confirming it to be a better strategy for reducing GIST progression. The gene discussed is BBC3; the disease is gastrointestinal stromal tumor.